Brief Pain Inventory

Abstract

The Brief Pain Inventory (BPI) is a widely used, self-administered questionnaire designed to assess the severity of pain and the degree to which pain interferes with daily functioning. Developed initially for assessing pain in cancer patients, the BPI has proven effective across various populations suffering from acute and chronic pain conditions. It provides a quick and reliable measure of both the intensity of the pain experience and its critical impact on several aspects of life, including general activity, mood, and sleep. The instrument is considered a gold standard in pain research and clinical settings due to its robust psychometric properties and ease of administration.

Keywords

Brief Pain Inventory, BPI, Pain assessment, Pain severity, Pain interference, Chronic Pain, Cancer pain, Numerical Rating Scale, Quality of life.

Authors

Charles S. Cleeland, Ronald L. Daut.

Purpose

The primary purpose of the Brief Pain Inventory is to quantify the multidimensional experience of pain. It is intended for use in clinical practice and research to track changes in pain levels and functional status over time, particularly in response to treatment interventions. The scale aims to capture not just the subjective intensity of pain, but also the resulting functional limitations that significantly diminish a patient’s quality of life.

The BPI is designed to be brief enough for routine clinical use while still providing comprehensive data on four key pain intensity items (worst, least, average, and current pain) and seven items measuring interference with general activities. This focus on both intensity and interference allows clinicians to develop more holistic treatment plans that address functional restoration alongside pain relief.

Construct

The BPI measures the construct of the pain experience, which is inherently multidimensional. This construct is typically broken down into two primary components or subscales: Pain Severity and Pain Interference. The Severity subscale captures the subjective intensity of the pain, utilizing a 0-10 Numerical Rating Scale (NRS) across different time points (worst, least, average, and current pain).

The Interference subscale assesses the functional and emotional impact of pain on seven specific areas of daily living, also using an 0-10 NRS where 0 indicates no interference and 10 indicates complete interference. These areas include general activity, mood, walking ability, normal work, relations with others, sleep, and enjoyment of life. By separating these two constructs, the BPI provides a nuanced understanding of how pain affects the patient beyond mere physical sensation.

Validity

Extensive research supports the validity of the Brief Pain Inventory across diverse populations and pain etiologies. Construct validity is demonstrated by the scale’s strong correlation with other established pain measures, such as the McGill Pain Questionnaire, particularly concerning intensity ratings. The differentiation between the Severity and Interference subscales further enhances its construct validity, as these dimensions correlate differently with quality of life outcomes.

The BPI exhibits strong criterion validity, showing sensitivity to change following clinical interventions, such as analgesic therapy or physical rehabilitation. Its ability to accurately reflect clinically meaningful changes in both pain intensity and functional status confirms its utility as a valid outcome measure in clinical trials and longitudinal studies focused on chronic pain management.

Reliability

The BPI demonstrates excellent internal consistency, a key measure of reliability. The Pain Severity subscale typically yields high Cronbach’s alpha coefficients, often ranging from 0.85 to 0.95 across various studies, indicating that its items measure a unified construct of intensity. Similarly, the Pain Interference subscale consistently shows strong internal consistency, often with alpha values above 0.90.

Furthermore, the BPI exhibits acceptable test-retest reliability, demonstrating stability over short periods when the patient’s pain condition is stable. This reliability ensures that observed changes in scores are likely attributable to genuine changes in the patient’s condition or treatment efficacy rather than random measurement error. The scale’s reliability has been successfully established across numerous translations and cultural adaptations.

Factor Analysis

Factor Analysis conducted on the BPI consistently supports a robust two-factor structure, corresponding precisely to the intended subscales: Pain Severity and Pain Interference. Initial exploratory and confirmatory factor analyses, particularly in cancer populations, isolated these two distinct, yet correlated, dimensions of the pain experience.

The Pain Severity factor is typically defined by items 3 (worst pain), 4 (least pain), 5 (average pain), and 6 (pain right now). The Pain Interference factor is defined by the seven interference items (A through G). This stable factor structure has been replicated across various cultures and disease states, confirming the BPI’s utility as a measure of the two most critical aspects of pain management outcomes.

Instrument

Test Type: Self-report questionnaire / Multidimensional Pain Assessment Tool

Format: Paper-and-pencil or electronic administration. Uses 0-10 Numerical Rating Scales (NRS) for severity and interference, a body diagram for location, and open/checkbox questions for qualitative data.

Language Available: Over 60 validated translations globally, including Spanish, Chinese, French, German, and numerous others.

Population Group: Individuals experiencing pain, initially developed for oncology patients.

Age Group: Typically adults (18+), though adapted versions exist for adolescents (e.g., BPI-A).

Population Details: Applicable to patients with acute pain, chronic non-malignant pain, and chronic pain associated with diseases such as cancer, arthritis, and fibromyalgia.

Test Methodology: Patients rate their pain intensity and the extent to which pain interferes with specific daily functions over the past week. Scoring involves calculating the mean score for the Severity subscale and the mean score for the Interference subscale.

Keywords

Pain intensity, Functional status, Quality of life measures, Pain relief, Oncology, Multidimensional assessment, Pain scale, Daut, Cleeland, Psychometrics.

Authors

Author ORCID Identifier: Not uniformly available or applicable for the original authors at the time of development.

Affiliation Email addresses: Contact information typically managed through the University of Texas MD Anderson Cancer Center, where Cleeland was affiliated.

Correspondence Address: Refer to the Department of Symptom Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Permissions & Fee and Test Year

The Brief Pain Inventory is generally available for non-commercial research and clinical use without charge, though formal permission is often required from the copyright holders (usually MD Anderson Cancer Center or the original developers). Commercial use typically requires a licensing agreement. The scale was developed based on the Wisconsin Brief Pain Questionnaire (1983), with the BPI being standardized and widely published in the early 1990s. The original PDF can be downloaded here: http://www.a4ebm.org/sites/default/files/Measuring%20Health.pdf.

Reference’s

• Daut, R.L., Cleeland, C.S. (1982) . The prevalence and severity of pain in cancer. Cancer, 50:1913–1918.

• Daut, R.L., Cleeland, C.S., Flanery, R.C. (1983). Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain, 17:197–210.

• Cleeland, C.S. (1985). Measurement and prevalence of pain in cancer. Semin Oncol Nurs, 1:87–92.

• Cleeland, C.S., Ladinsky, J.L., Serlin, R.C, et al. (1988). Multidimensional measurement of cancer pain: comparisons of U.S. and Vietnamese patients. J Pain Symptom Management, 3:23–27.

• Cleeland, C.S. Pain assessment in cancer. In: Osoba D, ed. Effect of cancer on quality of life. Boca Raton, Florida: CRC Press, 1991:293–305.

• Cleeland, C.S., Ryan, K.M. (1994). Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994;23:129–138.

• Cleeland, C.S., Gonin, R., Hatfield, A.K, et al. (1994). Pain and its treatment in outpatients with metastatic cancer. N Engl J Med, 330:592–596.

• McDowell, Ian. (2006). Measuring Health: A Guide to Rating Scales and Questionnaires, Third Edition. OXFORD UNIVERSITY PRESS

Items of the Brief Pain Inventory

IMPORTANT: The following scale items must be preserved in their original language and must not be changed in any way.